Inventor · disambiguated record
Christopher Scott
Also filed as: SCOTT CHRISTOPHER · SCOTT CHRISTOPHER DANIEL
7 granted patents·10 pending applications·2 citations·filing 2002–2025
71Inventor score
Files withFUSION ANTIBODIES LTD4FUSION ANTIBODIES PLC2SCOTT CHRISTOPHER2AVICEDA THERAPEUTICS INC1CASWELL JILL1
Top patents by PatentIndex Score
17 records- 0183US12209073B2Polymorphs of a dihydroorotate dehydrogenase (DHOD) inhibitorKIORA PHARMACEUTICALS GMBH·Filed 2023·Granted Jan 28, 2025·2 cites·20 claims
- 0263US2009149412A1Method for Inhibition of Phospholamban Activity for the Treatment of Cardiac Disease and Heart FailureUNIV CALIFORNIA·Filed 2008·Application pending·0 cites
- 0359US2025195689A1Glycomimetic ligandsAVICEDA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0458US2025382726A1Antibody Library and MethodFUSION ANTIBODIES PLC·Filed 2025·Application pending·0 cites
- 0550US12378696B2Antibody library and methodFUSION ANTIBODIES PLC·Filed 2019·Granted Aug 5, 2025·0 cites·8 claims
- 0647US8846868B2Anti-AREG/HB-EGF antibodies and treatmentCASWELL JILL·Filed 2009·Granted Sep 30, 2014·0 cites·11 claims
- 0743US8747849B2Antibody and uses thereofSCOTT CHRISTOPHER·Filed 2011·Granted Jun 10, 2014·0 cites·10 claims
- 0843US7939642B2Antibody and uses thereofFUSION ANTIBODIES LTD·Filed 2006·Granted May 10, 2011·0 cites·9 claims
- 0942US2023033582A1Polymeric nanoparticles for enhanced cancer treatmentUNIV BELFAST·Filed 2020·Application pending·0 cites
- 1042US2004121942A1Method for inhibition of phospholamban activity for the treatment of cardiac disease and heart failureFiled 2003·Application pending·0 cites
- 1141US2007110761A1Protein purification meansFUSION ANTIBODIES LTD·Filed 2003·Application pending·0 cites
- 1238US2006234222A1Soluble recombinant protein productionMCKEOWN BRENDAN·Filed 2002·Application pending·0 cites
- 1337US9321838B2Therapy targeting cathepsin SOLWILL SHANE·Filed 2007·Granted Apr 26, 2016·0 cites·5 claims
- 1437US2010086551A1Antibody and uses thereofFUSION ANTIBODIES LTD·Filed 2007·Application pending·0 cites
- 1537US2010111965A1Combination therapyFUSION ANTIBODIES LTD·Filed 2007·Application pending·0 cites
- 1634US2010104554A1Peptide and uses thereofFUSION ANTIBODIES LTD A CORP O·Filed 2007·Application pending·0 cites
- 1733US8962032B2ModulatorSCOTT CHRISTOPHER·Filed 2010·Granted Feb 24, 2015·0 cites·17 claims
Join the waitlist — get patent alerts
Get an alert when Christopher Scott files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →